1. Sensitivity analysis: oxytocin alone vs placebo/expectant mx; trials with adequate vs uncertain or inadequate allocation concealment.
Risk ratio with 95% confidence intervals: all women | RR adequate allocation concealment | RR uncertain or inadequate allocation concealment | |
Vaginal delivery not achieved within 24 hrs | 0.16 (0.10 to 0.25) | 0.14 (0.07 to 0.29) | 0.17 (0.09 to 0.33) |
Uterine hyperstimulation with FHR changes | 0.16 (0.01 to 3.34) | 0.16 (0.01 to 3.34) | No studies |
Caesarean section | 1.14 (0.95 to 1.37) | 1.14 (0.95 to 1.37) | 1.11 (0.82 to 1.49) |
Serious neonatal morbidity or death | 0.63 (0.26 to 1.51) | 0.38 (0.11 to 1.29) | 1.31 (0.33 to 5.22) |
Serious maternal morbidity or death | Not estimable | No studies | Not estimable |